These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Pi JH; Lee HK; Kim HS; Jang JJ; Kim CS; Kim SH; Lee JY; Yoo NJ Cancer Res; 1999 Jul; 59(13):3068-72. PubMed ID: 10397246 [TBL] [Abstract][Full Text] [Related]
5. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Han JY; Park GS; Dong SM; Pi JH; Kim CS; Kim SH; Lee JY; Yoo NJ Oncogene; 1999 Jun; 18(25):3754-60. PubMed ID: 10391683 [TBL] [Abstract][Full Text] [Related]
6. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype]. Nakatsuka S; Takakuwa T; Aozasa K Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395 [TBL] [Abstract][Full Text] [Related]
7. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Shin MS; Park WS; Kim SY; Kim HS; Kang SJ; Song KY; Park JY; Dong SM; Pi JH; Oh RR; Lee JY; Yoo NJ; Lee SH Am J Pathol; 1999 Jun; 154(6):1785-91. PubMed ID: 10362803 [TBL] [Abstract][Full Text] [Related]
8. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer. Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789 [TBL] [Abstract][Full Text] [Related]
10. Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma. Nakatsuka S; Takakuwa T; Tomita Y; Miwa H; Matsuzuka F; Aozasa K Lab Invest; 2000 Nov; 80(11):1651-5. PubMed ID: 11092525 [TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-7 and its receptor in thyroid lymphoma. Takakuwa T; Nomura S; Matsuzuka F; Inoue H; Aozasa K Lab Invest; 2000 Oct; 80(10):1483-90. PubMed ID: 11045564 [TBL] [Abstract][Full Text] [Related]
12. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes. Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746 [TBL] [Abstract][Full Text] [Related]
13. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma. Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026 [TBL] [Abstract][Full Text] [Related]
14. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1. Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441 [TBL] [Abstract][Full Text] [Related]
15. Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma. Aozasa K; Tajima K; Tominaga N; Katagiri S; Yonezawa T; Matsuzuka F; Kuma K; Sawada M Oncology; 1991; 48(1):65-71. PubMed ID: 1987500 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma. Takakuwa T; Hongyo T; Syaifudin M; Kanno H; Matsuzuka F; Narabayashi I; Nomura T; Aozasa K Jpn J Cancer Res; 2000 Mar; 91(3):280-6. PubMed ID: 10760686 [TBL] [Abstract][Full Text] [Related]
17. DNA sequence of immunoglobulin heavy chain variable region gene in thyroid lymphoma. Miwa H; Takakuwa T; Nakatsuka S; Tomita Y; Matsuzuka F; Aozasa K Jpn J Cancer Res; 2001 Oct; 92(10):1041-7. PubMed ID: 11676854 [TBL] [Abstract][Full Text] [Related]